Related Experiment Video
Updated: Sep 26, 2025

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
Targeted Degradation of 53BP1 Using Ubiquitin Variant Induced Proximity
Bayonle Aminu1, Julia Fux1, Evan Mallette1
1Department of Molecular and Cellular Biology, College of Biological Science, University of Guelph, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada.
Abstract:
In recent years, researchers have leveraged the ubiquitin-proteasome system (UPS) to induce selective degradation of proteins by E3 ubiquitin ligases, which has great potential as novel therapeutics for human diseases, including cancer and neurodegenerative disorders. However, despite extensive efforts, only a handful of ~600 human E3 ligases were utilized, and numerous protein-protein interaction surfaces on E3 ligases were not explored. To tackle these problems, we leveraged a structure-based protein engineering technology to develop a multi-domain fusion protein bringing functional E3 ligases to the proximity of a target protein to trigger its proteasomal degradation, which we termed Ubiquitin Variant Induced Proximity (UbVIP). We first generated non-inhibitory synthetic UbV binders for a selected group of human E3 ligases. With these UbVs employed as E3 ligase engagers, we designed a library of UbVIPs targeting a DNA damage response protein 53BP1. We observed that two UbVIPs recruiting RFWD3 and NEDD4L could effectively induce proteasome degradation of 53BP1 in human cell lines. This provides a proof-of-principle that UbVs can act as a means of targeted degradation for nucleus-localized proteins. Our work demonstrated that UbV technology is suitable to develop protein-based molecules for targeted degradation and can help identify novel E3 ligases for future therapeutic development.
Insights
Researchers developed Ubiquitin Variant Induced Proximity (UbVIP) technology to target proteins for degradation using the ubiquitin-proteasome system (UPS). This novel approach successfully degraded the 53BP1 protein, offering potential for new therapeutics against diseases like cancer.
Area of Science:
- Biochemistry
- Molecular Biology
- Proteomics
Background:
- The ubiquitin-proteasome system (UPS) is crucial for protein degradation and targeted by therapeutics for diseases like cancer.
- Limited utilization of ~600 human E3 ligases hinders therapeutic development, leaving many protein-protein interaction surfaces unexplored.
Purpose of the Study:
- To develop a novel protein-based technology for targeted protein degradation using engineered E3 ligases.
- To demonstrate the efficacy of Ubiquitin Variant Induced Proximity (UbVIP) in degrading specific target proteins.
Main Methods:
- Structure-based protein engineering was used to create multi-domain fusion proteins (UbVIPs).
- Synthetic Ubiquitin Variant (UbV) binders were generated to recruit E3 ligases.
- A library of UbVIPs was designed to target the DNA damage response protein 53BP1.
Main Results:
- Two UbVIPs, recruiting RFWD3 and NEDD4L E3 ligases, effectively induced proteasomal degradation of 53BP1 in human cell lines.
- This demonstrated UbV technology's capability for targeted degradation of nuclear proteins.
- The study provides a proof-of-concept for UbV technology in targeted protein degradation.
Conclusions:
- UbV technology offers a versatile platform for developing protein-based targeted degradation therapeutics.
- This approach can facilitate the identification and utilization of novel E3 ligases for therapeutic applications.
- UbVIP technology shows promise for treating cancers and neurodegenerative disorders by enabling targeted protein destruction.
Related Concept Videos
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
The Proteasome Structure
The proteasome is an...
Export of Misfolded Proteins out of the ER
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...

